| 0 |
ACQUIRED FACTOR V DEFICIENCY |
14 |
0.1273 |
| 1 |
COAGULATION FACTOR V LEVEL ABNORMAL |
14 |
0.1138 |
| 2 |
COAGULATION FACTOR DEFICIENCY |
14 |
0.0870 |
| 3 |
ASCENDING FLACCID PARALYSIS |
1 |
0.0370 |
| 4 |
FACTOR V LEIDEN MUTATION |
14 |
0.0353 |
| 5 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
14 |
0.0151 |
| 6 |
BACTERIAL TRACHEITIS |
1 |
0.0123 |
| 7 |
PNEUMONIA STREPTOCOCCAL |
3 |
0.0027 |
| 8 |
MULTIPLE ALLERGIES |
14 |
0.0018 |
| 9 |
CONGENITAL ANOMALY |
11 |
0.0014 |
| 10 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 11 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
3 |
0.0012 |
| 12 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
3 |
0.0012 |
| 13 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
6 |
0.0010 |
| 14 |
ARTHROPOD STING |
1 |
0.0006 |
| 15 |
SYSTEMIC CANDIDA |
1 |
0.0004 |
| 16 |
BRAIN DEATH |
1 |
0.0003 |
| 17 |
POSTURE ABNORMAL |
1 |
0.0003 |
| 18 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
14 |
0.0003 |
| 19 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 20 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
11 |
0.0002 |
| 21 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
14 |
0.0002 |
| 22 |
BLOOD PRESSURE SYSTOLIC INCREASED |
3 |
0.0002 |
| 23 |
ASTHMA |
15 |
0.0001 |
| 24 |
BRONCHOPULMONARY ASPERGILLOSIS |
1 |
0.0001 |
| 25 |
BLOOD PRESSURE FLUCTUATION |
3 |
0.0001 |
| 26 |
RHINITIS |
1 |
0.0001 |
| 27 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 28 |
CARDIOTOXICITY |
1 |
0.0001 |
| 29 |
DRY SKIN |
14 |
0.0001 |
| 30 |
HEART RATE DECREASED |
3 |
0.0001 |
| 31 |
ERYTHEMA |
15 |
0.0001 |
| 32 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 33 |
HYPERTENSION |
14 |
0.0001 |
| 34 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 35 |
SPINAL FRACTURE |
1 |
0.0000 |
| 36 |
SHOCK |
1 |
0.0000 |
| 37 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 38 |
PRURITUS |
15 |
0.0000 |
| 39 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 40 |
SEDATION |
1 |
0.0000 |
| 41 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 42 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 43 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 44 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 45 |
DYSPNOEA |
14 |
0.0000 |
| 46 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 47 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 48 |
ARRHYTHMIA |
1 |
0.0000 |
| 49 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 50 |
MEDICATION ERROR |
1 |
0.0000 |
| 51 |
OFF LABEL USE |
15 |
0.0000 |
| 52 |
COVID-19 |
3 |
0.0000 |
| 53 |
DRUG INEFFECTIVE |
21 |
0.0000 |
| 54 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 55 |
CARDIAC FAILURE |
1 |
0.0000 |
| 56 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 57 |
SYNCOPE |
1 |
0.0000 |
| 58 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 59 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 60 |
SEIZURE |
1 |
0.0000 |
| 61 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 62 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 63 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 64 |
FALL |
2 |
0.0000 |
| 65 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 66 |
CHEST PAIN |
1 |
0.0000 |
| 67 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 68 |
DECREASED APPETITE |
1 |
0.0000 |
| 69 |
BACK PAIN |
1 |
0.0000 |
| 70 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 71 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 72 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 73 |
DIARRHOEA |
2 |
0.0000 |
| 74 |
DEATH |
2 |
0.0000 |
| 75 |
NAUSEA |
1 |
0.0000 |